Trial Profile
A retrospective study comparing the efficacy of Gemtuzumab Ozagamicin with and without chemotherapy in patients with acute myeloid leukaemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2016
Price :
$35
*
At a glance
- Drugs Gemtuzumab ozogamicin (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 06 Sep 2016 New trial record